Objectives: Despite screening, disparities exist in cervical cancer incidence and outcomes. Demographic factors are associated with diagnosis at advanced stage (AS), but less is known about geographic factors. We sought to investigate risk factors for developing AS cervical cancer in Alabama.
C ervical cancer is a worldwide public health problem causing significant morbidity and mortality. It is the second most common cancer among women and accounts for almost 300,000 deaths worldwide per year. 1, 2 In the United States, more than 12,000 new women are diagnosed annually. 3, 4 Despite widespread screening and increasing uptake of human papillomavirus (HPV) vaccination, more than half of new diagnoses are advanced stage (AS), which carries high rates of morbidity and mortality as well as increased risk of recurrence. 4, 5 Similar to other healthcare disparities, the contributing factors to disparities in cervical cancer outcomes are multifactorial. 2, 6 Poverty, insurance status, and race have all been shown to negatively affect HPV vaccination series completion rates, Pap screening rates, and follow-up and treatment of abnormal Pap smear results. [7] [8] [9] [10] Furthermore, disparities in stage at diagnosis, guideline-adherent care and outcomes have been demonstrated for cervical cancer. [10] [11] [12] [13] Low socioeconomic status, lack of access to reliable transportation, lack of health insurance, and minority race have been shown to be associated with a diagnosis of AS cervical cancer. 2, 14, 15 In the United States, there is wide geographical variation in cervical cancer incidence and mortality rates with the highest rates seen in Appalachia, the South Atlantic, and lower Mississippi Valley. Alabama occupies the southernmost part of Appalachia. 16, 17 We have previously demonstrated the impact of distance from a comprehensive cancer center on overall survival in women diagnosed with cervical cancer, which highlights the importance of geographic location in obtaining and completing high-quality cancer treatment.
11 Geographic measures such as the distance to nearest women's health provider and residing in a rural area are potentially modifiable barriers to both prevention and treatment of cervical cancer; however, less is known about the effects of these factors on stage at diagnosis and their interaction with other factors that impact cervical cancer outcomes. Thus, we evaluated the geographic and sociodemographic risk factors for development of AS cervical cancer in our state.
MATERIALS AND METHODS
Our institutional tumor registry was queried to identify a cohort of women treated for cervical cancer from 2005 to 2015 at the University of Alabama at Birmingham. Patients diagnosed with American Joint Committee on Cancer Stages II-IV were considered to have AS cervical cancer. ZIP codes were defined as rural or urban based on 2010 federal Rural-Urban Commuting Area (RUCA) Codes. 18 ZIP codes were further categorized as Black Belt rural (BBR) if they were in 1 of 16 Black Belt counties, which are particularly medically underserved and rural with demonstrated disparities in other health outcomes whose population is approximately 50% African American (see Figure 1) . [19] [20] [21] [22] [23] Using data from the American College of Obstetricians and Gynecologists (ACOG), we identified practice locations of ACOG fellows in the state. A total of 442 ACOG fellows were identified including 383 fellows, 44 junior fellows, 8 associate members, and 7 senior status fellows. This was used as a proxy for women's health care providers. Estimated patient travel distance individually and combined with RUCA codes have been used by other investigators to evaluate geospatial effects of residence on cancer outcomes. α level of 0.05 for significance. SAS statistical software was used for analysis (SAS v9.4; SAS Institute, Cary, NC). This project was approved by our institutional review board.
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RESULTS
After exclusions, we identified 934 patients for the analysis. Of these, 273 (29.2%) patients were black and 661 (70.8%) were white. Mean (SD) age at diagnosis was 49.8 (14.7). There were 493 patients with AS cervical cancer including: 197 (21.1%) stage II, 210 (22.5%) stage III, and 86 (9.2%) stage IV. Five hundred ninety-two (63.4%) lived in urban areas and 342 (36.6%) in rural areas, including 85 in BBR areas (see Table 1 ). Mean distance to the nearest women's health provider for patients in urban, rural, and BBR areas was 5.0, 10.6, and 13.7 miles, respectively. Black women were significantly more likely to have public insurance compared with white women (p < .001) (see Table 2 ).
In the crude analysis, black race (odds ratio [OR] = 1.46; 95% confidence interval [CI] = 1.09-1.94), public insurance (compared with private, OR = 1.80; 95% CI = 1.35-2.40) and age of older than 65 years (OR = 1.95; 95% CI = 1.34-2.85) were associated with increased risk of being diagnosed with AS cervical cancer. A shorter minimum distance to nearest women's health Table 3 ). A significant interaction between race and insurance status on the outcome (p = .03) was noted; therefore, we conducted a stratified analysis by race. When stratified by race and adjusted for multiple factors in multivariate analysis, insurance status (both uninsured and public insurance) and older age were both associated with AS cancer in white women but not black women (see Table 4 ).
DISCUSSION
In our analysis, AS cervical cancer was diagnosed in more than half of cases, which indicates that there are ample opportunities for improvement in both prevention and early detection. We examined distance to nearest women's health provider with the hypothesis that this can affect both primary and secondary prevention leading to delayed diagnosis. As expected, distance to nearest women's health provider was greater in both rural and BBR ZIP codes. Interestingly, this longer distance was not associated with a higher risk of AS disease, with neither closer distance to the nearest provider or rurality associated with AS disease. Previous studies have shown that women who live in rural areas live farther from Pap screening and treatment services and that lack of access to reliable transportation is associated with a higher likelihood of AS disease. 2, 14, 15 Furthermore, other studies have demonstrated the negative impact of distance from treatment facility for patients after diagnosis of both ovarian and cervical cancer. 11, 25, 26 However, this analysis indicates that other factors, namely race, age, and insurance status, had a stronger influence on outcomes than did geography in our population.
When stratified by race, having public insurance and being uninsured were associated with AS cancer in white women but not black women. However, black women had a higher risk of AS cancer than white women regardless of age, insurance status, or geography. Our analysis is consistent with previous data showing that significant racial disparities exist and that black race remains one of the strongest predictors of worse outcomes for women with cervical cancer. 13, 27 This is important in the context of recent analyses that demonstrate that racial disparities in cervical cancer are historically underestimated. 13, 17 The high rate of public insurance or lack of insurance among women diagnosed with cervical cancer in our series, as well as the association of insurance status with AS cervical cancer in white women reinforces the fact that funding status is an influential determinant of health disparities. Eliminating racial disparity, improving access to care, and increasing insurance coverage are key determinants to the success in prevention and treatment of cervical cancer. 8, 9, 28 The strengths of our study include a large number of cases from a high-volume cancer center, minimal changes in management of AS disease during the study period, and a wide range of variables available for analysis. 29 However, there are several limitations. Although our tumor registry accounts for approximately 30% of the population in our state with cervical cancer, the use of a single institution tumor registry may limit the sociodemographic distribution of patients and does not identify those treated elsewhere within the state. Furthermore, histologic cancer type was not available for this analysis, which could affect results as nonsquamous cancers are more likely to present at AS. The use of ACOG data to identify women's health providers may underestimate the number of medical professionals who provide preventive treatment for women, especially in rural areas. However, abnormal screening results require referral to physicians who offer biopsy or excisional procedures. These providers should be best identified by ACOG data. Our data do not include information regarding patient or provider mobility during the study period, which could alter the geographic relationships between providers and patients over time. Women of racial/ethnic groups other than white and black were excluded because of their low numbers, and data were not available to control for individual medical comorbidities. Generalizability of these results may be limited because our results are representative of the outcomes resulting from screening, diagnosis, and treatment within our state's healthcare delivery system.
CONCLUSIONS
Our study demonstrates that access to care is a complex concept that cannot be equated solely to distance to care. There are other person-level mediators of access to care such as access to transportation, which may make distance more or less important depending on the population in question. Furthermore, there may be a threshold above or below, in which distance becomes a vital mediator of access. Such evaluations are outside the scope of our investigation. However, this concept underlines the fact that attempts to identify and eliminate outcomes disparities must involve multiple disciplines including basic science, public health, epidemiology, and clinical medicine and be specific to the target population. For example, HPV subtype and histologic differences by race have been demonstrated in cervical cancer, highlighting the importance of promoting racially diverse models for investigation of tumor biology and response to treatments. 30, 31 Improvements in public health infrastructure to eliminate barriers to screening, early diagnosis, and high-quality cancer therapy must be advocated for at the local, state, and national levels. Race, socioeconomic status, and insurance status are determinants of initiation of HPV vaccination, adherence to screening guidelines, and access to appropriate treatment. All of these should be targets for reducing incident cancer cases. [7] [8] [9] Stage at diagnosis, rates of guideline-adherent care and mortality are worse for nonwhite women. 32 Eliminating health disparities will require committed investigation to elucidate more targeted sources of inequitable care and outcomes. 2, 6, 33 
